Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Penederm and Alpharma enter marketing agreement

Feb. 5, 1998

New anti-PCP agent is more potent than pentamidine

Feb. 5, 1998

Salivary peptide fragment may be useful for oral candidiasis

Feb. 5, 1998

Favorable clinical safety, pharmacokinetics and anti-CMV activity reported for 1263W94

Feb. 5, 1998

Glaxo Wellcome characterizes in vitro/in vivo antibacterial activity of new trinem

Feb. 4, 1998

Shaman suspends phase II trial of Virend

Feb. 3, 1998

Trovan soon to be available in pharmacies

Feb. 3, 1998

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

RiboGene and Dainippon join forces in antibacterial collaboration

Feb. 2, 1998

Roche discloses inhibitors of bacterial dihydrofolate reductase

Feb. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...